ArticleBMC cancer2016

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study.

Takayuki Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.